Abstract
The iron-sulfur (Fe-S) cluster (ISC) biogenesis pathway is indispensable for many fundamental biological processes and pathogenic variations in genes encoding several components of the Fe-S biogenesis machinery, such as NFU1, BOLA3, IBA57 and ISCA2 are already implicated in causing four types of multiple mitochondrial dysfunctions syndromes (MMDS) among other human diseases. MMDS are clinically characterized by neurodevelopmental delay, neurological deterioration, lactic acidosis, extensive white matter abnormalities and early death. We report on two unrelated families, with two affected children each with neurodevelopmental delay, regression of developmental milestones, seizures, extensive white matter abnormalities, cortical migrational abnormalities, lactic acidosis and early demise. Exome sequencing of two affected individuals, one from each family, revealed a homozygous c.259G>A variant in ISCA1 and Mendelian segregation was confirmed in both families. ISCA1 is a specialized factor known to mediate maturation of distinct Fe-S cluster (ISC) proteins. In silico functional analyses and structural modeling of the protein predict the identified ISCA1 variant to be detrimental to protein stability and function. Notably the phenotype observed in all affected subjects with the ISCA1 pathogenic variant is similar to that previously described in all 4 types of MMDS. The ISCA1 variant lies in the only shared region of homozygosity between the two families suggesting the possibility of a founder effect. To the best of our knowledge this is the first instance where ISCA1 deficiency has been shown to be associated with a human disease, a new type of multiple mitochondrial dysfunctions syndrome.
Iron-sulfur (Fe-S) clusters (ISCs) are small inorganic cofactors of metalloproteins found in bacteria and eukaryotes that are indispensable for cellular processes such as respiration, protein translation, purine metabolism, DNA repair and gene expression regulation. Magnetic resonance spectroscopy showed elevated lipid lactate peak in her brain. They succumbed to the disease at the age of 11 months and 2 years 3 months respectively. We note the phenotype observed in all affected subjects in both families is similar to that previously described for all four types of MMDS. Complete clinical details for both families are provided in Table 1 . This research work has the approval of the institutional ethics committee. Specific parental consent was obtained for the use of photographs, clinical and research findings for publication.
Whole exome sequencing (WES) was carried out as described previously to achieve an average coverage depth of 100-130x, such that ~95% of the bases are covered at >20x, with a sensitivity of >90%. 13 WES raw data was processed using SeqMule and the called variants were annotated with ANNOVAR. [14] [15] [16] Variants were filtered against public databases such as 1000
Genomes Project phase 3, Exome Aggregation Consortium v.0.3.1 (ExAC), National Heart, Lung, and Blood Institute Exome Sequencing Project Exome Variant Server (ESP6500SI-V2)
and an in-house database (~139 exomes) and those with a minor allele frequency >1% were excluded. Additionally, variants flagged as low quality or putative false positives (Phred quality score <20, low quality by depth <20) were excluded from the analysis. The overall variant filtering strategy is outlined in Table S1 . In view of the consanguinity and phenotype of mitochondrial disorder, we looked for homozygous variants in IscA proteins are highly conserved and fundamental to the physiology of prokaryotes and eukaryotes. The human ISCA1 was first identified in a subject with Sjogren's syndrome as a potential target of autoimmune antibodies. 17 It was found to be abundantly expressed in human and rat brain and kidneys. 17 It shares 38% identity and 70% similarity to E.coli Isca and similar to its bacterial counterpart. 17; 18 The above reported variant appears to have an impact on the functional Fe-S biogenesis domain of ISCA18 ( Figure S1B ), at a residue that is highly conserved, as indicated by Clustal Omega multiple sequence alignment ( Figure 1K ) and ConSurf ( Figure 2A , 2B, 2C), with a PhyloP score of 7.442. Additionally we note that the harmful nature of this variation is suggested by its occurrence at residue 87 that lies within a region of 48-90 residues of ISCA1, delineated previously to be instrumental for mediating ISCA1 interaction with IOP1 (iron-only hydrogenase-like protein 1), that plays a role in cytosolic Fe-S protein assembly pathway. 19 Several functional in silico prediction tools were also used to interrogate the damaging consequences of the p.Glu87Lys variation. MutationTaster predicted it to be 'disease-causing', similarly the Sorting Intolerant from Tolerant (SIFT) algorithm and Protein Variation Effect Analyzer (Provean) indicate this alteration to be 'damaging'. The presently reported missense ISCA1 variation was also predicted to be highly deleterious with a CADD score of 22.5. 20 This was corroborated by Position Specific Evolutionary Preservation (PANTHER-PSEP) analyses that predicts this SNV to be probably damaging on account of it occurring at an amino acid position estimated to be preserved for ~455 million years. Screening for Nonacceptable Polymorphisms (SNAP2), a web-based tool that combines a variety of information pertaining to evolutionary conservation, secondary structure and solvent accessibility of the protein predicted the p.E87K variant to have a severe detrimental effect with a score of 80 and accuracy of 91%.
We used three dimensional (3D) protein structure modeling to assess the structural impact of native acidic Glu87 being replaced by the basic mutant Lys87 residue in the mutant ISCA1. The 3D structure model of wild-type human ISCA1 (UniProt accession: Q9BUE6) and the mutant c.259G>A (p.Glu87Lys) proteins were predicted using SWISS-MODEL web-server.
Homology modeling was carried out on the basis of the crystallographic structure of E. coli SufA (sequence similarity of 37.61% to the human ISCA1) that is involved in biosynthesis of Fe-S clusters (PDB ID: 2D2A). The visualization of the protein structure was done using the locally installed YASARA View simulation software. 21 The Ramachandran plot for native and mutant ISCA1 were generated using RAMPAGE server and were of good quality. In both 90.7% of the all residues were observed in the favored region, with 8.4% in the allowed region and only 0.9% in the outlier region ( Figure 2D, 2E Since the two probands are of Indian origin and from the same geographic location (family 1 was consanguineous and family 2 denied any consanguinity) and the same pathogenic variant is identified in both of them, we explored the possibility of a founder effect. After examining the homozygous regions around the ISCA1 variant in both the probands, generated by the exome sequencing data, we identified only one overlapping region of homozygosity spanning 3.3 Mb in chromosome 9 (Chr9: 85613354-88925774) flanking the variant ( Figure S3) suggesting the possibility of a founder mutation in the local population (Table S2 and Table S3 ).
The genes within the shared region are given in Table S4 .
To conclude, we describe two independent families, both with two affected children each, with a severe neurodevelopmental disorder associated with a homozygous c.259G>A variant in 
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(D,E) The Ramachandran plots for wild-type and mutant ISCA1.
In both (D) wild-type and (E) mutant structures, 90.7% of the all residues were observed in the favoured, 8.4% in the allowed and 0.9% in the outlier regions Note that the favored, allowed and outlier regions are indicated in dark blue, light blue and white. 
